Stitchantrakul Wasana, Sopassathit Wichai, Prapaipanich Surasing, Domrongkitchaiporn Somnuek
research Center, Mahidol University, Bangkok.
Southeast Asian J Trop Med Public Health. 2004 Dec;35(4):1028-33.
It has been speculated that calcium supplement in subjects with low oxalate intake might increase the risk of calcium stone formation due to an increase in calcium absorption without a significant reduction in oxalate absorption. There have been no human studies addressing specifically the effects of taking calcium supplements in populations whose dietary oxalate is low. This study was conducted to determine the effects of calcium supplements on the risk of calcium stone formation in a population with low oxalate intake. Thirty-two healthy male navy privates, 22.7 +/- 1.9 (mean +/- SD) years old, who had oxalate intake of less than 1 mmol/day, a serum creatinine of less than 150 micromol/l, and no history of renal stones, participated in the study. Dietary oxalate was controlled to be under 1 mmol/day throughout the study. Twenty-four hour urine collections for the determination of urinary constituents were obtained at baseline and after taking calcium supplements. Detection of calcium oxalate was performed to assess the risk of calcium oxalate stone formation. The urinary excretion of calcium was significantly elevated above baseline values while taking the calcium supplements (3.48 +/- 2.13 vs 5.17 +/- 2.61 mmol/d, p < 0.05) and urinary oxalate was significantly decreased when the subjects took calcium supplements compared to the corresponding baseline value (0.13 +/- 0.05 vs 0.17 +/- 0.07 mmol/d, p = 0.01). Urinary citrate was significantly elevated when the subjects took calcium supplements compared to the baseline (0.83 +/- 0.57 vs 0.64 +/- 0.39 mmol/d, p = 0.03). There was no significant alteration in the activity products of calcium oxalate while taking the calcium supplements (0.54 +/- 0.25 vs 0.57 +/- 0.22, p = 0.54). The effect of calcium supplements with meals, for the reduction of the risk of calcium stone formation, was unchanged, even in a population whose oxalate intake is rather low. Taking calcium supplements resulted in a reduction in urinary oxalates and an elevation in urinary citrates. Both alterations in urinary constituents counterbalanced the elevation in urinary calcium which resulted from the calcium supplements.
据推测,对于草酸盐摄入量低的受试者,补充钙可能会增加草酸钙结石形成的风险,因为钙吸收增加而草酸盐吸收没有显著减少。目前尚无针对饮食中草酸盐含量低的人群补充钙的具体影响的人体研究。本研究旨在确定补充钙对草酸盐摄入量低的人群中草酸钙结石形成风险的影响。32名健康男性海军新兵参与了该研究,他们的年龄为22.7±1.9(平均±标准差)岁,草酸盐摄入量低于1 mmol/天,血清肌酐低于150 μmol/l,且无肾结石病史。在整个研究过程中,饮食草酸盐被控制在1 mmol/天以下。在基线期和补充钙后,收集24小时尿液以测定尿液成分。进行草酸钙检测以评估草酸钙结石形成的风险。补充钙时,尿钙排泄量显著高于基线值(3.48±2.13 vs 5.17±2.61 mmol/d,p<0.05),与相应基线值相比,受试者补充钙时尿草酸盐显著降低(0.13±0.05 vs 0.17±0.07 mmol/d,p = 0.01)。与基线相比,受试者补充钙时尿枸橼酸盐显著升高(0.83±0.57 vs 0.64±0.39 mmol/d,p = 0.03)。补充钙时草酸钙的活性产物没有显著变化(0.54±0.25 vs 0.57±0.22,p = 0.54)。即使在草酸盐摄入量相当低的人群中,随餐补充钙对降低草酸钙结石形成风险的效果也没有改变。补充钙导致尿草酸盐减少,尿枸橼酸盐升高。尿液成分的这两种变化抵消了补充钙导致的尿钙升高。